首页|血清CHI3L1水平与肝脏疾病之间的关系

血清CHI3L1水平与肝脏疾病之间的关系

扫码查看
目的 通过壳多糖酶3样蛋白1(chitinase 3-like protein 1,CHI3L1)在慢性乙型肝炎(chronic hepatitis B,CHB)、自身免疫性肝病(autoimmune liver disease,AILD)、肝硬化(liver cirrhosis,LC)、肝癌(hepatocellular carcinoma,HC)中的水平,为临床监测肝脏疾病进展提供依据.方法 选取菏泽市立医院2022年6月至2023年12月健康体检者60例、慢性乙型肝炎患者60例、自身免疫性肝病患者60例、肝硬化患者60例、肝癌患者60例作为研究对象,应用酶联免疫吸附(ELISA)法检测所有研究对象血清中CHI3L1表达水平;应用流式细胞检测细胞因子表达水平;生化分析仪检测生化指标水平.结果 CHI3L1水平,健康体检组(47.00±20.50ng/mL)<CHB 组(91.75±35.58ng/mL)<AILD 组(128.30±41.92ng/mL)<LC 组(131.29±46.52ng/mL)<HC组(154.07±59.92ng/mL).以健康体检组为对照,CHI3L1 诊断 LC 的 ROC 曲线显示,AUC 为 0.965;CHI3L1诊断HC的ROC曲线显示AUC为0.974.以慢性乙型肝炎组为对照,CHI3L1诊断肝硬化的值AUC为0.749(P<0.001),CHI3L1+AST诊断肝硬化AUC值为0.845(P<0.001),优于CHI3L1检测;以慢性乙型肝炎组为对照,AFP 诊断 HC 的 AUC 为 0.783,CHI3L1 诊断 HC 的 AUC 为 0.800(P<0.001);CHI3L1+AFP 诊断 HC 的 AUC 为0.891,CHI3L1+AST+IL-17+IL-6 诊断肝癌的 AUC 为 0.937(P<0.001),优于 CHI3L1 和 AFP 检测.结论 血清 CHI3L1表达水平在肝癌组中最高,慢性乙型肝炎组最低,血清CHI3L1表达水平随疾病进展升高;血清CHI3L1可作为辅助诊断肝硬化和肝癌的无创指标;血清CHI3L1、AST、IL-6、IL-17、IL-8、IFN-γ联合检测能够提高对肝硬化和肝癌的诊断.
The Relationship Between Levels of Serum CHI3L1 and Liver Disease
Objective To investigate the role of Chitinase 3-like protein 1(CHI3L1)in Chronic Hepatitis B(CHB)and Autoimmune Liver disease,AILD),Liver Cirrhosis(LC),and Hepatocellular Carcinoma(HC),and to provide a knowledge basis for clinical monitoring of liver disease progression.Methods Sixty healthy subjects,60 patients with chronic hepatitis B,60 patients with autoimmune liver disease,60 patients with cirrhosis and 60 patients with liver cancer from Heze Municipal Hospital from June,2022 to December,2023 were selected as the study objects.Serum CHI3L1 expression levels of all subjects were detected by enzyme-linked immunoadsorption(ELISA)method.The expression level of cytokines was detected by flow cytometry.Biochemical analyzer was used to measure the level of biochemical indexes.Results CHI3L1 level measure showed pattern as follows:health examination group(47.00±20.50ng/mL)<CHB group(91.75±35.58ng/mL)<AILD group(128.30±41.92 ng/mL)<LC group(131.29±46.52ng/mL)<HC group(154.07±59.92)ng/mL).ROC curve of CHI3L1 for LC diagnosis had an AUC of 0.965.ROC curve for CHI3L1 diagnosis of HC had an AUC of 0.974.If chronic hepatitis B group was used as control,AUC of CHI3L1 in the diagnosis of cirrhosis was 0.749(P<0.001),and that of CHI3L1+AST in the diagnosis of cirrhosis was 0.845(P<0.001),which was better than that of CHI3L1 alone.In chronic hepatitis B group,AUC for AFP diagnosis was 0.783,and that for CHI3L1 diagnosis was 0.800(P<0.001).AUC of CHI3L1+AFP in the diagnosis of HC was 0.891,and that of CHI3L1+AST+IL-17+IL-6 in the diagnosis of HCC was 0.937(P<0.001),which was better than that of CHI3L1 and AFP.Conclusion Serum CHI3L1 expression level is the highest in liver cancer group and the lowest in chronic hepatitis B group,and serum CHI3L1 expression level increases with disease progression.Serum CHI3L1 can be used as a non-invasive index in the diagnosis of liver cirrhosis and liver cancer.Serum CHI3L1,AST,IL-6,IL-17,IL-8,IFN-γ combined detection can improve the diagnosis of liver cirrhosis and liver cancer.

Chitinase 3-like protein 1Hepatitis BAutoimmune Liver diseaseLiver cirrhosisLiver cancer

周煜苗、张卫、宗金宝

展开 >

青岛大学,山东青岛 266000

菏泽医学专科学校,山东菏泽 274000

菏泽市立医院,山东菏泽 274000

青岛大学附属青岛市海慈医院检验科,山东青岛 266000

展开 >

CHI3L1 乙型肝炎 自身免疫性肝病 肝硬化 肝癌

中国博士后科学基金第60批面上项目一等资助青岛市博士后应用研究项目

2016M6005232016050

2024

标记免疫分析与临床
中国同辐股份有限公司

标记免疫分析与临床

CSTPCD
影响因子:0.978
ISSN:1006-1703
年,卷(期):2024.31(8)